tirzepatide vision problems #Mounjaro & eyesight…. 2025 reality. The “blindness” stories are mostly about NAION (an eye-stroke). A large study found a very small increase (0.04% vs 0.02%) in people on #semaglutide / #tirzepatide Vision loss: GLP-1 drugs like

A phase 2 trial raised some safety questions, including a possible signal for cardiac arrhythmias well revisit this shortly [13]

25.57 Dermal nevus: the formation of pseudovascular spaces as shown in this example is a common artifact

Most women prefer a non-invasive treatment and are interested in pursuing uterus-preserving treatments, yet fibroids are still the leading cause of a woman undergoing a hysterectomy

Davis PA, Yokoyama W

Heres a breakdown of how 2.5 mg Tirzepatide is typically administered in a research context: Subcutaneous (SC) Injection: This is the preferred method for Tirzepatide administration

Take it with food, or eat within 30 minutes, and your absorption drops significantly